Big Money Flowing for Obesity at Pfizer and Roche
September 22, 2025 — Yesterday Pfizer announced a $7.3 billion deal to buy Metsera, a company with an impressive obesity drugs portfolio. Roche, having spent $2.7 billion to acquire Carmot in 2023 and $1.6 billion in March on a deal with Zealand, yesterday confirmed its intent to spend everything it takes to become a market leader in obesity. “We […]
